The evaluation of residual kidney function in patients with ckd vd and approaches of its preservation

  • L. Surzhko SI «Institute of Nephrology NAMS of Ukraine»
Keywords: residual kidney function, chronic kidney disease, hydration, renal replacement therapy, evaluation of GFR, hemodiafiltration, hemodialysis, peritoneal dialysis.


The work is a literature review. Residual kidney function (RKF) is one of the crucial indicators of mortality and quality of life in patients with chronic kidney disease. Residual renal function provides better control of hydration, blood pressure, clearance of substances with low and middleweight, anemia, Ca/P metabolism, chronic inflammation. However, approaches to preservation of RKF in dialysis patients have been studied not enough, the importance of RKF preservation is underlined. The wide range of predictors of RKF loss are presented in the article, approaches to measurement of RKF, the relationship between level and presence of RKF with survival and mortality of patients with CKD 5D were analyzed. The possibility of RKF preservation and extension using different approaches by correction of dialysis prescription were estimated. There is no standardized method for applying incremental hemodialysis in practice. Onceto twice-weekly hemodialysis regimens are often used randomly, without knowing the benefit for current patient or how to escalate the dialysis dose if RKF declines over time. It is important to change the HD/HDF prescription according to the range of RRF using objective data.


Download data is not yet available.


Shafi, T, Levey AS. Measurement and Estimation of Residual Kidney Function in Patients on Dialysis. Adv Chronic Kidney Dis. 2018;25(1):93-104. doi: 10.1053/j.ackd.2017.09.001

Hemodialysis Adequacy Work Group. Clinical practice guidelines for hemodialysis adequacy, up- date 2006. Am J Kidney Dis. 2006;48(1):2-90. doi: 10.1053/j.ajkd.2006.03.051

Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemo- dialysis patients. Am J Kidney Dis. 2001;38:85-90. doi:10.1053/ajkd.2001.25198

Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT, NECOSAD  SG.  Relative  contribution  of   resid- ual renal function and different measures of ad- equacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative  Study  on the Adequacy of Dialysis (NECOSAD)-2. J  Am Soc Nephrol. 2004;15:1061-70. doi: 10.1097/01. ASN.0000117976.29592.93.

Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, et al. Association of residual urine output with mortality, quality of life, and inflamma- tion in incident hemodialysis patients: The choices for healthy outcomes in caring for end-stage re- nal disease (CHOICE) Study. Am J Kidney Dis. 2010;56:348-58.  doi:  10.1053/j.ajkd.2010.03.020.

Shafi T, Michels WM, Levey AS, Inker LA, Dekker FW, Krediet RT, et al. Estimating residual kidney function in dialysis patients without urine collec- tion. Kidney Int. 2016;89:1099-10. doi: 10.1016/j. kint.2015.10.011.

Levey AS. Measurement of renal function in chronic renal disease. Kidney Int. 1990;38:167-84. doi:10.1016/0034-5288(95)90044-6

Simonsen O, Grubb A, Thyssel H.  The  blood  se- rum  concentration  of   cystatin-C   (gamma-trace) as a measure of the glomerular filtration rate. Scand J Clin Lab Invest, 1985;5:97-101. doi: 10.3109/00365518509160980

White CA, Ghazan-Shahi S, Adams MA. β-Trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis. 2015;65:131-46. doi: 10.1053/j.ajkd.2014.06.038

Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease pa- tients: diagnostic accuracy of urinary β-trace pro- tein. Am J Physiol Renal Physiol. 2010;299:1407- 23. doi: 10.1152/ajprenal.00507.2009

National KF. KDOQI Clinical Practice Guideline for Hemodialysis  Adequacy:  2015  update.  Am J Kidney Dis. 2015;66:884-930. doi: 10.1053/j. ajkd.2015.07.015

Lee MJ, Park JT, Park KS, Kwon YE, Oh HJ, Yoo TH, et al. Prognostic Value of Residual Urine Volume, GFR by24-hour Urine Collection, and eGFR in Patients Receiving Dialysis. Clin J Am Soc Nephrol. 2017;12:426–34. doi: 10.2215/ CJN.05520516

Kjaergaard KD, Jensen JD, Peters CD, Jespersen B. Preserving residual renal function in dialysis patients: an update on evidence  to  assist  clini- cal decision making. NDT Plus. 2011;4:225-30. doi: 10.1093/ndtplus/sfr035


Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glo- merular filtration rate from serum creatinine: a new prediction equation.  Modification  of  Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461-70. doi: 10.7326/0003-4819-130-6-199903160-00002

Levey AS, Stevens LA, Schmid CH, et al. for the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006

Woitas RP, Stoffel-Wagner B, Poege U et al. Low- molecular weight proteins as markers for glomeru- lar filtration rate. Clin Chem. 2001;47: 2179-80.

Inker LA, Schmid CH, Tighiouart H et al. for the CKD-EPI Investigators. Estimating  glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20–29. doi: 10.1056/ NEJMoa1114248

Van Olden RW, Krediet RT, Struijk DG, Arisz L. Measurement of residual renal function in patients treated with continuous ambulatory peritoneal di- alysis. J Am Soc Nephrol. 1996;7(5):745-50.

Delanaye P, Ebert N, Melsom T, et al. Iohexol plas- ma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 1: how to measure glomerular filtration rate with iohexol? Clin Kidney J. 2016;9(5):682-99. doi: 10.1093/ckj/sfw070

Shafi T, Levey AS, Inker LA, et al. Plasma iohexol clearance for assessing residual kidney function in dialysis patients. Am J Kidney Dis. 2015;66(4):728- 30. doi: 10.1053/j.ajkd.2015.06.010 Shafi T, Levey AS, Coresh J. In reply to plasma clearance of io- hexol in hemodialysis patients requires prolonged blood sampling. Am J Kidney Dis. 2016;67(5):811- 12. doi: 10.1053/j.ajkd.2016.01.023

Shafi T, Levey AS, Coresh J. In reply to plasma clearance of iohexol in hemodialysis patients re- quires prolonged blood sampling. Am J Kidney Dis. 2016;67(5):811-12.  doi:  10.1053/j.ajkd.2016.01.023

Walser M. Determinants of ureagenesis, with particular reference to renal failure. Kidney Int. 1980;17(6):709-21.  doi:  10.1038/ki.1980.84

Jacobsen FK, Christensen CK, Mogensen CE, Andreasen F, Heilskov NS. Pronounced increase in serum creatinine concentration after eating cooked meat. Br Med J. 1979;1(6170):1049-50

Lubowitz H, Slatopolsky E, Shankel S, Rieselbach RE, Bricker NS. Glomerular filtration rate. Determination in patients with chronic renal dis- ease. JAMA. 1967;199(4):252-6. doi:10.1001/ jama.1967.03120040062010

Lavender S, Hilton PJ, Jones NF. The measure- ment of glomerular filtration rate in renal dis- ease. Lancet. 1969;2(7632):1216-18. doi: 10.1016/ S0140-6736(69)90752-1

Milutinovic J, Cutler RE, Hoover P, Meijsen B, Scribner BH. Measurement of residual glomerular filtration rate in the patient receiving repetitive he- modialysis. Kidney Int. 1975;8(3):185-90.

Bargnoux AS, Pieroni L, Cristol JP, et al. Multicenter evaluation of cystatin C measurement after assay standardization. Clin Chem. 2017;63(4):833-41. doi:   10.1373/clinchem.2016.264325

Argyropoulos   CP,   Chen   SS,   Ng   Y-H,   et   al. Rediscovering beta-2 microglobulin as a biomarker across the spectrum of kidney diseases. Front Med. 2017;4:73.   doi:10.3389/fmed.2017.00073

White CA, Ghazan-Shahi S, Adams MA. β-Trace protein: a marker of GFR and other biological pathways. Am J Kidney Dis. 2015;65:131-46. doi: 10.1001/jama.2015.6731

Seronie-Vivien S, Delanaye P, Pieroni L, et al. Cystatin C. current position and future prospects. Clin Chem Lab Med. 2008;46(12):1664-86. doi: 10.1515/CCLM.2008.336

Liu X, Foster MC, Tighiouart H, et al.  Non- GFR determinants of low-molecular-weight se- rum protein filtration markers in CKD. Am J Kidney Dis. 2016;68(6):892-900. doi: 10.1053/j. ajkd.2016.07.021

Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Performance of serum cystatin C versus serum cre- atinine as a marker of glomerular filtration rate as measured by inulin renal clearance. Clin Exp Nephrol. 2011;15(6):868-76. doi: 10.1016/S0140- 6736(69)90752-1

Donadio C. Serum and urinary markers of early impairment of GFR in chronic kidney disease pa- tients: diagnostic accuracy of urinary β-trace pro- tein. Am J Physiol Renal Physiol 2010;299:1407- 23. doi: 10.1152/ajprenal.00507.2009

Hoffmann A, Nimtz M, Conradt HS. Molecular characterization of beta-trace  protein  in  human serum and urine: a potential diagnostic marker for renal diseases. Glycobiology. 1997;7:499-506

Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, et al. GFR estimation us- ing beta trace  protein  and  beta2-microglobulin in CKD. Am J Kidney Dis. 2016;67:40-8. doi: 10.1053/j.ajkd.2015.07.025

Pöge U, Gerhardt T, Woitas RP. Estimation of glo- merular filtration  rate by  use of  beta-trace  pro- tein. Clin Chem. 2008;54:1403-05. doi: 10.1373/ clinchem.2007.101840

White CA, Akbari A, Doucette S, Fergusson D, Hussain N, Dinh L, et al. A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem. 2007;53:1965-68. doi: 10.1373/ clinchem.2007.090126

Wong J, Sridharan S, Berdeprado J, Vilar E, Viljoen A, Wellsted D, et al. Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin. Kidney Int 2016;89:1090-98. doi:  10.1016/j.kint.2015.12.042

Gerhardt T, Pöge U, Stoffel-Wagner B, Klein B, Klehr HU, Sauerbruch T, et al. Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients. Nephrol Dial Transplant. 2008;23:309-14. doi: 10.1093/ndt/gfm510

Van Craenenbroeck AH, Bragfors-Helin AC, Qureshi AR, Lindholm B, Sjöberg B, Anderstam B, et al. Plasma Beta-Trace Protein as a Marker of Residual Renal Function: The Effect of Different Hemodialysis Modalities and Intra-Individual Variability over Time. Kidney Blood Press Res 2017;42:877-85.  doi:  10.1159/000484537

Van Olden RW, van Acker BA,  Koomen  GC, Krediet RT, Arisz L. Time course of inulin and cre- atinine clearance in the interval between two hae- modialysis treatments. Nephrol Dial Transplant. 1995;10:2274-80.

Maiorca R, Brunori G, Zubani R et al. Predictive val- ue of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant. 1995; 10: 2295-2305.

Peritoneal Dialysis Study Group. Adequacy of dial- ysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada–USA (CANUSA) J Am Soc Nephrol. 1996;7:198-207.

Bargman JM,  Thorpe  KE, Churchill  DN.  Relative contribution of residual renal function and peri- toneal clearance to adequacy of dialysis: a reanal- ysis of the CANUSA study. J Am Soc Nephrol. 2001;12:2158-62.

Shemin D, Bostom AG, Laliberty P, Dworkin LD. Residual renal function and mortality risk in hemo- dialysis patients. Am J Kidney Dis. 2001;38:85-90. doi:  10.1053/ajkd.2001.25198

Van der Wal WM, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT, Korevaar JC, et al. Netherlands Cooperative Study on the Adequacy of Dialysis Study Group (NECOSAD): Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structur- al model. Nephrol Dial Transplant. 2011;26:2978– 83. doi: 10.1093/ndt/gfq856

Liao CT, Chen YM, Shiao CC, Hu FC, Huang JW, Kao TW, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term perito- neal dialysis. Nephrol Dial Transplant, 2009; 24: 2909–14. doi: 10.1093/ndt/gfp056

Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, et al. Residual kidney function decline and mortality in incident hemodialysis patients. J Am Soc Nephrol. 2016;27:3757–67. doi: 10.1681/ ASN.2015101142

Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V. Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial  Transplant.  2012;27:2404–10.  doi: 10.1093/ndt/gfr678

Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556-64

Davenport A. Will incremental hemodialysis pre- serve residual function and improve patient sur- vival? Semin Dial. 2015;28:16–9. doi: 10.1111/ sdi.12320

Lin XI, Yan Y, Ni Z, et al. Clinical outcome of twice- weekly hemodialysis patients in shanghai. Blood Purif. 2012;33:66-72. doi: 10.1159/000334634

Hwang HS, Hong YA, Yoon HE, et al. Comparison of Clinical  Outcome  Between  Twice-Weekly and Thrice-Weekly Hemodialysis in  Patients With  Residual  Kidney  Function.   Fourtounas. C, ed. Medicine. 2016;95(7):2767 doi: 10.1097/ MD.0000000000002767

Obi Y, Streja E, Rhee CM, Ravel V, Amin AN, Cupisti A, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident di- alysis patients: A cohort study. Am J Kidney Dis. 2016;68(2):256-65.   doi:10.1053/j.ajkd.2016.01.008

Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, et al. Effect of frequent he- modialysis on residual kidney function. Kidney Int. 2013;83:949–58.  doi:  10.1038/ki.2012.457

Kjaergaard KD, Peters CD, Jespersen B, Tietze IN, Madsen JK, Pedersen BB, et al. Angiotensin block- ade and progressive loss of kidney function in he- modialysis patients: A randomized controlled trial. Am J Kidney Dis. 2014;64:892–901. doi:10.3410/f.718488740.793499064

Abstract views: 267
PDF Downloads: 140
How to Cite
Surzhko, L. (2018). The evaluation of residual kidney function in patients with ckd vd and approaches of its preservation. Ukrainian Journal of Nephrology and Dialysis, (2(58), 41-48.